Senior management must ensure that all members are team players. From an overall perspective, effective marketing requires good management of this team and this is where pharmaceutical consultants are worth their weight in gold. The team members must be able to quantify and visualise and objectives must be controlled and measured at all times. The daily initiatives must be seen as part of an overall and tangible goal and the team should be able to work as a cohesive unit for best results to be achieved.

After planning is complete, the sales force must put it into action. There is a time and a place for the planning and charting of the program, but no sales are made until executives interact in the real world. While a sales team may be composed of experienced players, there is nevertheless a lot to learn about the health care industry in particular and training is an essential part of staff handling. A poorly educated sales team may be unaware of some significant problems that they could encounter, resulting in wasted time and potential clients lost to other competitors. In most cases, pharma consulting firms fully understand how important time management is and how effective implementation is not possible in the wider scheme without strict adherence and application.

It is never good to assume anything, as this could lead to confusion and delay. Effective implementation requires a level of awareness that comes as part of a true playing team. Each member has a significant contribution to make and these contributions should be visible and not opaque. Once again, the overall goal is to engage and not to procrastinate. An effective sales person must be assertive, outgoing and creative.

When in the marketplace, the salesman or woman must be fully up to speed on product details, benefits, solutions and item availability, but must also be an effective manager, able to prioritise and still achieve stated benchmarks and goals. Effective implementation requires core skills, but also ongoing training and perfect management, both for the individual and for a marketing force as a whole. Invariably, pharmaceutical consulting organisations are primed and ready to take on these challenges.

Alan Gillies is the Managing Director of L2L Consulting, specialising in enabling pharmaceutical companies to achieve new heights of productivity and performance, throughout all levels of management and revenue generating activities.

Pharmaceutical companies face a significant challenge, even as they are poised to make considerable contributions toward the overall health of the population. Scientific breakthroughs may enable the company to come up with a truly magnificent product, certain to benefit the health of the nation, but a long way from distribution due to obstacles in its path. The creative brains at the top must be backed up by experienced lobbyists and by first-class sales and marketing teams. While the company should concentrate on its core values, it could enlist the services of pharmaceutical consultants to ensure that sellers and marketing teams are fully trained and ready to hit the ground running.

You could say that there are a lot of moving parts in the life of a healthcare product as it travels from the company to the suffering patients. At the beginning of the line, investors and regulatory authorities must be on the same page before the product may be created, made available to marketers, sold to healthcare professionals and pharmacists with the blessing of the financiers. The patient may never get to know that such a product even exists unless the pharmaceutical company's marketing initiatives are top-notch.

A pharma consulting company is fully aware of the complexities of the industry and has a significant background. Consultants will have hands-on experience, not text book smarts and be very aware of the loopholes and pitfalls that a company may face ahead.

The biggest monetary investment a company makes is generally in its workforce. Without proper incentives, the best tools and knowledge base, the workforce cannot be of best value to the company. Sales executives must be instilled with the ability to bring the company's product to the attention of the buyer and must be ready to counter all obstacles that will undoubtedly be put in their way.

The pharmaceutical company is strongly advised to retain a leading consulting organisation. A company that stretches itself too thinly may end up taking resources away from its core areas of expertise. The consulting firm is poised to take on the responsibility of training and motivation within the fields of sales and marketing, and to help ensure that the pharmaceutical company achieves its goals.

Alan Gillies is the Director of L2L Consulting, an elite pharmaceutical consultancy firm which specialises in Strategy Development and Implementation Excellence for prestigious multi-national organisations.

Senior management must ensure that all members are team players. To ensure that the ultimate marketing results are achieved, the team must be effectively managed and pharmaceutical consultants are fully positioned to do this. The team members must be able to quantify and visualise and objectives must be controlled and measured at all times. Day by day programs are part of an ultimate and achievable goal and when a team works together as one, good results can be anticipated.

After planning is complete, the sales force must put it into action. There is a time and a place for the planning and charting of the program, but no sales are made until executives interact in the real world. While a sales team may be composed of experienced players, there is nevertheless a lot to learn about the health care industry in particular and training is an essential part of staff handling. Without adequate coaching and being unaware of potential loopholes ahead, time can be wasted and worse still, clients can be overlooked or lost in such a competitive marketplace. As they have a considerable amount of experience in the industry, pharma consulting firms appreciate time management and know that full application and dedication is required before key results may be achieved.

Never assume, as this inevitably leads to confusion and poor productivity. To be effective, the sales team member must be fully aware of the cohesive importance of a true team. Celebrate the contribution of each team member and make sure that it is completely visible to all concerned. Once again, the overall goal is to engage and not to procrastinate. Three critical components make up an effective salesperson – creativity, assertiveness and flair.

When in the marketplace, the salesman or woman must be fully up to speed on product details, benefits, solutions and item availability, but must also be an effective manager, able to prioritise and still achieve stated benchmarks and goals. Effective implementation requires core skills, but also ongoing training and perfect management, both for the individual and for a marketing force as a whole. Invariably, pharmaceutical consulting organisations are primed and ready to take on these challenges.

Alan Gillies is the CEO of L2L Consulting, a cutting-edge pharma consultancy firm which specialises in optimising productivity and performance within international companies by applying tailored organisational strategies.

Pharmaceutical companies must conform to strict FDA regulations, best use practices and study scientific benchmarks to provide products and services for ongoing use. Marketing plays a critical role in this arrangement and is far more than just a means to an end. The physician or pharmacist has to juggle a lot of information, much of it based on older science, together with the wants and needs of the patient and budgetary restrictions applied by insurance companies or individual positions.

The direct communication between health care professionals and the pharmaceutical companies through various marketing channels ultimately dictates the efficient delivery of products and services to the end-user, the patient. It follows that the standard of this marketing and its effectiveness directly contributes to the patient's ability to live a longer, healthier and more productive life. It’s crucial to remember that these forms of marketing represent a two way street. The company must not only communicate the benefits and risks of its product to the professional, the reasoning and science behind its introduction and instructions for its use, but the professional must give real world feedback and crucial data to the company.

The contribution of pharma consulting should never be underestimated as it can help to emphasise how certain conditions can be treated by emerging products and help to reveal how other illnesses, previously under-served, could be addressed. We still have many conditions without a cure and pharmaceutical company research can often go a long way to bridging that gap, if not even enabling cutting-edge treatment for patients. Just because the pharmaceutical products may exist, it does not mean that these products will find their way into the hands of the consumer. Marketing plays a critical role in disseminating the information from one end of the chain to the other, into the hands of the professionals for communication with the patient.

As more and more information is revealed through scientific study, product creation and government rubber-stamping, more of a spotlight is turned on the need for treatment of chronic diseases. As such, any by-products or side effects of new solutions may not become known, nor the link between cure and original illness exposed, unless strong marketing channels are open between all concerned.

In most instances, pharmaceutical consulting firms can also play a critical role in educating clients, producers and users. Their experience, knowledge and enthusiasm can really help to turn the wheels of the marketing machine, continuously engaging all key players and producing incredible results in such a competitive environment.

Alan Gillies is the Director of L2L Consulting, an elite pharmaceutical consultancy firm which specialises in Strategy Development and Implementation Excellence for prestigious multi-national organisations.

A pharmaceutical company is far more than just a manufacturer of health products and solutions. The pharmaceutical consulting firm helps the company understand how it needs to educate the consumer. Most often, the pharmaceutical companies are at the cutting-edge of science and help to uncover solutions or possibilities previously unheard-of. Without an adequate marketing channel, these findings might never make their way via the regulators to the front-line professionals. Those with a financial interest, especially the all important insurers, will also benefit from a good marketing approach, as they will be made aware of the positive features and benefits associated.

Before a new product may arrive on the desk of the regulators, who determine its future, the company must have marketed both its products and its history within a very competitive and busy environment. There are a lot of vested interests to take into account and some of these interests may promote older or generic medications, sometimes to the general detriment of the patient. Pharmaceutical companies must create a position within such a difficult marketplace, in order to push science and discovery and their own significant position forward.

Sometimes, the vested interests are very powerful and do not serve the ultimate client best. While healthcare reform and especially its associated finances remain a hot button issue, the pharmaceutical company must do everything in its power to ensure that its lines of communication are open. The physician takes input from many different sources before he or she makes the decision as to final care, including experience, peer input, education and training, patient history, formularies, techniques and benchmarks - all play their role. If you consider that nine out of ten most frequently prescribed drugs are generics, it should be clear that far from being in a position of dominance, pharmaceutical companies must make every effort to ensure that their marketing messages are heard. In most cases, pharma consulting firms are used to this difficult environment and can certainly help to open channels and engage practices.

Pharmaceutical companies have been responsible for many of the most amazing discoveries in the world of medicine. Previous generations would surely marvel at some of the cures available today. To enable healthcare to continue to get better, much emphasis must be placed on marketing.

Alan Gillies is the CEO of L2L Consulting, a cutting-edge pharma consultancy firm which specialises in optimising productivity and performance within international companies by applying tailored organisational strategies.

A pharmaceutical company is far more than just a manufacturer of health products and solutions. As a pharmaceutical consulting firm stresses, the company owes the consumer in general a debt of revelation. Pharmaceutical companies regularly operate on the sharp end of discovery and their revelations may be truly ground-breaking. If they have not paid sufficient attention to marketing, all the exploratory work may fail as the path through the regulators to the professionals may seem unclear. Those with a financial interest, especially the all important insurers, will also benefit from a good marketing approach, as they will be made aware of the positive features and benefits associated.

Before a new product may arrive on the desk of the regulators, who determine its future, the company must have marketed both its products and its history within a very competitive and busy environment. There are a lot of vested interests to take into account and some of these interests may promote older or generic medications, sometimes to the general detriment of the patient. Pharmaceutical companies must create a position within such a difficult marketplace, in order to push science and discovery and their own significant position forward.

It is unfortunate that the ultimate care of the patient is very often not the ultimate goal of certain vested interests. While healthcare reform and especially its associated finances remain a hot button issue, the pharmaceutical company must do everything in its power to ensure that its lines of communication are open. The harried physician must listen to many different interested parties before a decision can be made about the patient, including the views of other professionals, training and education, patient restrictions, formularies, best practices and traditions. If you consider that nine out of ten most frequently prescribed drugs are generics, it should be clear that far from being in a position of dominance, pharmaceutical companies must make every effort to ensure that their marketing messages are heard. Generally, pharma consulting firms play their part in helping to establish channels and best practices.

Many of the most striking advances in the dissemination of medicine in recent years have been a result of work by pharmaceutical companies. Cures that would have been unheard-of a generation ago are now commonplace. Much emphasis must be put on marketing “the word” to ensure that our health care continues to improve.

Alan Gillies is the Managing Director of L2L Consulting, specialising in enabling pharmaceutical companies to achieve new heights of productivity and performance, throughout all levels of management and revenue generating activities.

Senior management must ensure that all members are team players. From an overall perspective, effective marketing requires good management of this team and this is where pharmaceutical consultants are worth their weight in gold. The team members must be able to quantify and visualise and objectives must be controlled and measured at all times. The daily initiatives must be seen as part of an overall and tangible goal and the team should be able to work as a cohesive unit for best results to be achieved.

After planning is complete, the sales force must put it into action. Although you cannot underestimate the importance of planning and preparation, sales executives must now venture into the real world. No matter the amount of experience, the healthcare industry is particularly complex and all these intricacies must be part of an ongoing education. A poorly educated sales team may be unaware of some significant problems that they could encounter, resulting in wasted time and potential clients lost to other competitors. As they have a considerable amount of experience in the industry, pharma consulting firms appreciate time management and know that full application and dedication is required before key results may be achieved.

Never assume, as this inevitably leads to confusion and poor productivity. To be effective, the sales team member must be fully aware of the cohesive importance of a true team. Each member has a significant contribution to make and these contributions should be visible and not opaque. Eliminate procrastination and encourage action. Three critical components make up an effective salesperson – creativity, assertiveness and flair.

When in the marketplace, the salesman or woman must be fully up to speed on product details, benefits, solutions and item availability, but must also be an effective manager, able to prioritise and still achieve stated benchmarks and goals. Certain key skills must be in evidence before success may be achieved, but this can certainly be enhanced by full training, great management and team cohesiveness. Invariably, pharmaceutical consulting organisations are primed and ready to take on these challenges.

Alan Gillies is the Director of L2L Consulting, an elite pharmaceutical consultancy firm which specialises in Strategy Development and Implementation Excellence for prestigious multi-national organisations.

The population relies on the advances made by pharmaceutical companies as health levels improve, but these companies are facing a lot of challenges nonetheless. Through cutting edge developments, a company may create products able to make a significant difference to the health of the nation, but may yet face considerable obstacles before such products could be brought to market. In addition to scientific and creative expertise, the company must ensure that its sales and marketing and lobbying teams are top-notch. A company should always concentrate on what it does best and in this case bring in pharmaceutical consultants to train and manage sales and marketing teams adequately.

You could say that there are a lot of moving parts in the life of a healthcare product as it travels from the company to the suffering patients. The pharmaceutical company must first satisfy investors and regulators before a product can be brought to creation and must then be able to market its features, benefits and availability to healthcare professionals, pharmacists and to those who hold the purse strings, in many cases the insurance companies. This is a difficult path and the patient may not even get to know about the option unless the pharmaceutical company has a first-class marketing set up.

A pharma consulting company will have extensive background in the pharmaceutical industry and be very aware of the complex interactions between all the players. Consultants will have hands-on experience, not text book smarts and be very aware of the loopholes and pitfalls that a company may face ahead.

One of the largest costs for a company is usually its workforce. The workforce must be correctly incentivised and must be in full possession of all the tools and knowledge to help the company grow. Sales executives must be instilled with the ability to bring the company's product to the attention of the buyer and must be ready to counter all obstacles that will undoubtedly be put in their way.

The pharmaceutical company is strongly advised to retain a leading consulting organisation. Without such help, the company may find itself stretched very thinly and be unable to focus on its core needs. A consulting firm will train and motivate the sales and marketing team so that they are perfectly placed to be of service to the host organisation.

Alan Gillies is the Managing Director of L2L Consulting, specialising in enabling pharmaceutical companies to achieve new heights of productivity and performance, throughout all levels of management and revenue generating activities.